We demonstrated that Piezo1 activation promoted the initiation of TCMK-1 injury and fibrosis through the Bax/caspase3 pathway, but whether Piezo1 can be an intervention target in the development of CKD fibrosis is unclear. Here, PIEZO1 is linked to chronic kidney disease.